Abstract | OBJECTIVE: To analyze the clinical, hormonal, anatomical, and molecular characteristics of Leydig cell tumors, a very rare cause of progressive hyperandrogenism in children. STUDY DESIGN: RESULTS: Boys (n = 24) are younger than girls (n = 12) at diagnosis (median 6.5 vs 13.0 years, P = .04). Plasma gonadotrophins are more often completely suppressed in boys (6 cases) than in girls (2 cases). Pure Leydig cell tumors are exceedingly rare in girls (2 cases), who most often have Sertoli-Leydig tumors. These tumors affect either testis equally (11 left, 13 right) but occur more often in the left ovary (8 left, 3 right). Activating mutations of the alpha-subunit of the G(s) stimulatory protein have not been found in either boys or girls and activating mutations of the luteinizing hormone receptor have only been found in boys. CONCLUSIONS: Leydig cell tumors in children display clinical, hormonal, anatomical, and molecular sexual dimorphism.
|
Authors | Patricia Olivier, Judith Simoneau-Roy, Diane Francoeur, Hervé Sartelet, Jasmine Parma, Gilbert Vassart, Guy Van Vliet |
Journal | The Journal of pediatrics
(J Pediatr)
Vol. 161
Issue 6
Pg. 1147-52
(Dec 2012)
ISSN: 1097-6833 [Electronic] United States |
PMID | 22727875
(Publication Type: Case Reports, Journal Article, Review)
|
Copyright | Copyright © 2012 Mosby, Inc. All rights reserved. |
Chemical References |
- Biomarkers
- Genetic Markers
- Gonadotropins
|
Topics |
- Biomarkers
(blood)
- Child
- Female
- Genetic Markers
- Gonadotropins
(blood)
- Humans
- Leydig Cell Tumor
(blood, diagnosis, genetics)
- Male
- Ovarian Neoplasms
(blood, diagnosis, genetics)
- Phenotype
- Sex Factors
- Testicular Neoplasms
(blood, diagnosis, genetics)
|